You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

 

45 Results
Guidelines and Advice
Sep 2011
Guidelines and Advice
Sep 2011
Drug
Other Name(s): AMSA P D® (Erfa)
Sep 2011
Drug
Other Name(s): Vidaza®
Sep 2025
Drug
Other Name(s): Arimidex®
Updated
Dec 2025
Drug
Other Name(s): Trisenox®
Oct 2025
Drug
Other Name(s): Alecensaro®
Nov 2025
Drug
Other Name(s): Tecentriq™
Jul 2025
Regimen
Cancer Type:
Lung, 
Non-Small Cell
Intent: Palliative
Funding:
Exceptional Access Program
    alectinib - Treatment of ALK-positive locally advanced or metastatic non-small cell lung cancer, according to specific criteria
Dec 2025
Regimen
Cancer Type:
Skin, 
Merkel Cell
Intent: Palliative
Funding:
New Drug Funding Program
    Avelumab - Metastatic Merkel Cell Carcinoma
Jan 2025
Drug
Other Name(s): Bavencio™
Jan 2025
Regimen
Cancer Type:
Lung, 
Non-Small Cell
Intent: Palliative
Funding:
New Drug Funding Program
    Atezolizumab - Advanced or Metastatic Non-Small Cell Lung Cancer
New Drug Funding Program
    Atezolizumab - Advanced or Metastatic Non-Small Cell Lung Cancer
Jun 2025

Pages